Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors

Huang, Y., Kwan, M. L., Heckbert, S. R., Smith, N. L., Othus, M., Laurent, C. A., Roh, J. M., Rillamas-Sun, E., Lee, V. S., Kolevska, T., Cheng, R. K., Irribarren, C., Nguyen-Huynh, M., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2025). Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf009
Authors:
Yuhan Huang
Marilyn L. Kwan
Susan R. Heckbert
Nicholas L. Smith
Megan Othus
Cecile A. Laurent
Janise M. Roh
Eileen Rillamas‐Sun
Valerie S. Lee
Tatjana Kolevska
Richard K. Cheng
Carlos Irribarren
Mai N. Nguyen‐Huynh
Dawn L. Hershman
Lawrence H. Kushi
Heather Greenlee
Affiliated Authors:
Dawn L. Hershman
Publication Type:
Article
Unique ID:
10.1093/jncics/pkaf009
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: